XML 35 R26.htm IDEA: XBRL DOCUMENT v3.22.1
Financial Instruments and Fair Value Measurements (Tables)
6 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of Cash and Cash Equivalents
The following reconciles cash and equivalents and restricted cash reported within the Company's consolidated balance sheets at March 31, 2022 and September 30, 2021 to the total of these amounts shown on the Company's consolidated statements of cash flows:
(Millions of dollars)March 31, 2022September 30, 2021
Cash and equivalents$3,147 $2,283 
Restricted cash173 109 
Cash and equivalents and restricted cash$3,320 $2,392 
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The fair values of the Company’s financial instruments are as follows:
(Millions of dollars)Basis of fair value measurementMarch 31, 2022September 30, 2021
Institutional money market accounts and ultra-short bond fund (a)Level 1$609 $200 
Current portion of long-term debt (b)Level 21,056 503 
Long-term debt (b)Level 217,576 18,537 
(a)These financial instruments are recorded within Cash and equivalents on the consolidated balance sheets. The institutional money market accounts permit daily redemption. The fair values of these investments are based upon the quoted prices in active markets provided by the holding financial institutions.
(b)Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments.
Transfer of Financial Assets Accounted for as Sales The amounts transferred and yet to be remitted under factoring arrangements are provided below.
Three Months Ended March 31,Six Months Ended March 31,
(Millions of dollars)2022202120222021
Trade receivables transferred to third parties under factoring arrangements$323 $364 $478 $856 
March 31, 2022September 30, 2021
Amounts yet to be collected and remitted to the third parties$237 $130